Gaviscon, mint suspension 300 ml

Geviscon® enters the stomach and interacts with its contents to form a protective barrier (raft) that prevents the onset of heartburn.

Geviscon® is an antacid.

Pharmacodynamics

When taken orally, Gaviscon reacts quickly with the acidic contents of the stomach. This forms an alginate gel that prevents the occurrence of gastroesophageal reflux. In regurgitation, the gel is more likely than the stomach contents to enter the esophagus, where it reduces mucosal irritation.

Pharmacokinetics

The mechanism of action of Gaviscon is independent of absorption into the systemic bloodstream.

Indications

Symptomatic treatment of dyspepsia associated with increased acidity of gastric juice and gastroesophageal reflux (heartburn, sour belching); feeling of heaviness in the stomach after eating, incl. during pregnancy.

Pharmacological effect

Gaviscon® enters the stomach and interacts with its contents, forming a protective barrier (raft) that prevents heartburn.

Gaviscon is an antacid.

Pharmacodynamics

When taken orally, Gaviscon reacts quickly with the acidic contents of the stomach. This forms an alginate gel, which prevents the occurrence of gastroesophageal reflux. During regurgitation, the gel is more likely than the stomach contents to enter the esophagus, where it reduces irritation of the mucous membrane.

Pharmacokinetics

The mechanism of action of Gaviscon does not depend on absorption into the systemic circulation.

Special instructions

In 10 ml of suspension the sodium content is 141 mg (6.2 mmol). This should be taken into account when a salt-restricted diet is required, for example in some cases of congestive heart failure and in cases of impaired renal function.

If there is no improvement in symptoms within 7 days, you should consult your doctor.

Active ingredient

Sodium alginate, Sodium bicarbonate, Calcium carbonate

Composition

10 ml of suspension contains:

Active substances:

sodium alginate 500 mg;

sodium bicarbonate;

calcium carbonate;

Excipients:

carbomer;

methyl parahydroxybenzoate;

propyl parahydroxybenzoate;

sodium saccharinate;

peppermint oil;

sodium hydroxide;

purified water.

Pregnancy

Gaviscon can be used during pregnancy and breastfeeding.

Contraindications

Hypersensitivity to the components of the drug; children under 6 years of age.

Side Effects

Allergic reactions are possible.

Overdose

Symptoms: Abdominal bloating may occur.

Treatment: symptomatic therapy.

Short product description

Gaviscon®, oral suspension [mint]. When taken orally, Gaviscon® forms a protective barrier on the surface of the stomach contents, preventing the reflux of stomach acid into the esophagus for up to four hours.
A decrease in irritation is felt 3-4 minutes after administration.

The mechanism of action of the active substances of Gaviscon® is physical and does not depend on absorption into the systemic circulation.

Storage conditions

Store at temperatures between 15 °C and 25 °C. Keep out of the reach of children.

Shelf life

3 years

Manufacturer

Reckitt Benckiser Healthcare (UK) Limited, UK